High-dose methotrexate: insecure rationale: take 2.

Barton A Kamen

Journal: Journal of pediatric hematology/oncology 2008;30(9):639-40

PMID: 18776753

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Robert Wood Johnson Medical School, New Brunswick, NJ, USA. [email protected]

DOI: 10.1097/MPH.0b013e318185f4ee

Link outs

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...
https://doi.org/10.1097/MPH.0b013e318185f4ee

MeSH Terms: Dose-Response Relationship, Drug, Folic Acid, Folic Acid Antagonists, Humans, Methotrexate

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.